New developments in the treatment of metastatic gastric cancer: focus on trastuzumab

by Rose, Jeffrey S, Bekaii-Saab, Tanios S
Published 2011

CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer

by Wu, Christina, Bekaii-Saab, Tanios
Published 2012

Management of Venous Thromboembolism in Patients with Advanced Gastrointestinal Cancers: What Is the Role of Novel Oral Anticoagulants?

by Martin, Ludmila Katherine, Bekaii-Saab, Tanios
Published 2012

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

by Bekaii-Saab, Tanios, Williams, Nita, Plass, Christoph, Calero, Miguel Villalona, Eng, Charis
Published 2006

Adjuvant therapy for pancreas cancer in an era of value based cancer care

by Ahn, Daniel H., Williams, Terence M., Goldstein, Daniel A., El-Rayes, Bassel, Bekaii-Saab, Tanios
Published 2015

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors

by Ahn, Daniel H., Ozer, Hatice Gulcin, Hancioglu, Baris, Lesinski, Gregory B., Timmers, Cynthia, Bekaii-Saab, Tanios
Published 2015

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-4212

by Henderson, Sally E., Ding, Li-Yun, Mo, Xiaokui, Bekaii-Saab, Tanios, Kulp, Samuel K., Chen, Ching-Shih, Huang, Po-Hsien
Published 2016

Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer...

by Overholser, Jay, Ambegaokar, Kristen Henkins, Eze, Siobhan M., Sanabria-Figueroa, Eduardo, Nahta, Rita, Bekaii-Saab, Tanios, Kaumaya, Pravin T.P.
Published 2015

Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients

by Mace, Thomas A, Pitaressi, Jason, Shakya, Reena, Frankel, Wendy, Eubank, Tim, Bekaii-Saab, Tanios, Bloomston, Mark, Phelps, Mitch, Ludwig, Thomas, Ostrowski, Michael, Lesinski, Gregory B
Published 2013

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer

by Ahn, Daniel H., Li, Junan, Wei, Lai, Doyle, Austin, Marshall, John L., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Bekaii-Saab, Tanios
Published 2015

Appendiceal Mixed Adeno-Neuroendocrine Carcinoma: A Population-Based Study of the Surveillance, Epidemiology, and End Results Registry

by Brathwaite, Shayna, Yearsley, Martha M., Bekaii-Saab, Tanios, Wei, Lai, Schmidt, Carl R., Dillhoff, Mary E., Frankel, Wendy L., Hays, John L., Wu, Christina, Abdel-Misih, Sherif
Published 2016

Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

by Mikhail, Sameh, Ciombor, Kristen, Noonan, Anne, Wu, Christina, Goldberg, Richard, Zhao, Weiqiang, Wei, Lai, Mathey, Kristina, Yereb, Melissa, Timmers, Cynthia, Bekaii-Saab, Tanios
Published 2015

Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer

by Mace, Thomas, Shakya, Reena, Pitarresi, Jason, Loftus, Shannon, Swanson, Benjamin, Young, Gregory, Zhong, Xioling, Zimmers, Teresa, Ostrowski, Michael, Ludwig, Thomas, Bloomston, Mark, Bekaii-Saab, Tanios, Lesinski, Gregory
Published 2015

Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients

by Farren, Matthew R, Mace, Thomas, Geyer, Susan, Mikhail, Sameh, Wu, Christina, Ciombor, Kristen, Tahiri, Sanaa, Ahn, Daniel, Noonan, Anne, Villalona-Calero, Miguel, Bekaii-Saab, Tanios, Lesinski, Gregory
Published 2015

BMS-911543 inhibits viability of tumor and stromal cells and limits disease progression in genetically engineered mice with pancreatic cancer

by Mace, Thomas, Shakya, Reena, Swanson, Benjamin, Ludwig, Thomas, Elnaggar, Omar, Komar, Hannah, Yang, Jennifer, Young, Gregory, Frankel, Wendy, Muscarella, Peter, Bekaii-Saab, Tanios, Bloomston, Mark, Lesinski, Gregory
Published 2014

Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion

by Yang, Jennifer, Keenan, Kaitlin, Mace, Thomas, Ferren, Matthew, Bekaii-Saab, Tanios, Fuchs, James, Schwartz, Eric, Li, Chenglong, Pui-Kai Li, Jiayuh Lin, Lesinski, Gregory
Published 2014

Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer

by Chatterjee, Moumita, Ben-Josef, Edgar, Thomas, Dafydd G., Morgan, Meredith A., Zalupski, Mark M., Khan, Gazala, Andrew Robinson, Charles, Griffith, Kent A., Chen, Ching-Shih, Ludwig, Thomas, Bekaii-Saab, Tanios, Chakravarti, Arnab, Williams, Terence M.
Published 2015

Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer

by Mace, Thomas A., Shakya, Reena, Elnaggar, Omar, Wilson, Kristin, Komar, Hannah M., Yang, Jennifer, Pitarresi, Jason R., Young, Gregory S., Ostrowski, Michael C., Ludwig, Thomas, Bekaii-Saab, Tanios, Bloomston, Mark, Lesinski, Gregory B.
Published 2015

Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome

by Shaib, Walid, Krishna, Kavya, Kim, Sungjin, Goodman, Michael, Rock, Jonathan, Chen, Zhengjia, Brutcher, Edith, Staley, Charles III, Maithel, Shishir K., Abdel-Missih, Samih, El-Rayes, Bassel F., Bekaii-Saab, Tanios
Published 2016

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

by Markowitz, Joseph, Abrams, Zachary, Jacob, Naduparambil K, Zhang, Xiaoli, Hassani, John N, Latchana, Nicholas, Wei, Lai, Regan, Kelly E, Brooks, Taylor R, Uppati, Sarvani R, Levine, Kala M, Bekaii-Saab, Tanios, Kendra, Kari L, Lesinski, Gregory B, Howard, J Harrison, Olencki, Thomas, Payne, Philip R, Carson, William E
Published 2016